There are 2789 resources available
1733P - Analysis of chemotherapy (Ct) efficacy according to histology in malignant pleural mesothelioma (MPM) patients (p)
Presenter: Susana Cedres
Session: ePoster Display
1734P - Genomic landscape of pleural and peritoneal mesothelioma tumors
Presenter: Stefanie Hiltbrunner
Session: ePoster Display
1735P - Circulating T-cell immunosenescence in patients with thymic epithelial tumors (TETs)
Presenter: Jose Carlos Benitez Montanez
Session: ePoster Display
1736P - Prognostic factors predicting survival in malignant pleural mesothelioma: A retrospective study in two Spanish hospitals
Presenter: Mora Guardamagna
Session: ePoster Display
1737P - Prognosis of metastatic sites in heart-specific death of cancer patients
Presenter: Mohammed Hussein Omar Safi
Session: ePoster Display
1738P - Association of ZNF479 mutation with tumor mutation burden and survival in lung cancer patients treated with immune checkpoint inhibitors
Presenter: Zhong Lou
Session: ePoster Display
1739P - Survival outcomes in patients with sarcomatoid pleural mesothelioma: A retrospective analysis from the last two decades
Presenter: Rajiv Shah
Session: ePoster Display
1740P - Track and treat in NSCLC (TATIN) - ctDNA guided treatment of early resistance to second-line osimertinib treatment in patients with EGFR mutation positive (EGFRm) NSCLC
Presenter: Merel Jebbink
Session: ePoster Display
1741P - Malignant effusion-derived non-small cell lung cancer organoid might be a feasible in vitro model for therapeutic screening
Presenter: Han-Min Wang
Session: ePoster Display
1742TiP - RADIORYTHMIC: Phase III, opened, randomized study of post-operative radiotherapy (PORT) versus surveillance in stage IIb/III of Masaoka Koga thymoma after complete surgical resection
Presenter: Clemence Basse
Session: ePoster Display